军事知识服务平台
A foundation model-enhanced CT radiomics signature for the noninvasive assessment of tertiary lymphoid structures and prediction of therapy benefit in gastric cancer
摘要 Gastric cancer is a highly heterogeneous tumor type whose treatment responses substantially vary across patients.In recent years,biomarkers have shown promise in guiding individualized treatment regimens for gastric cancer,par-ticularly for targeted therapy and immunotherapy1.Existing biomarkers,including CD8+T-cell infiltration,PD-L1 expres-sion,microsatellite instability,and tumor mutational burden,remain insufficient to reliably stratify patients for chemother-apy or immunotherapy benefit1-3.Therefore,robust,clinically applicable,noninvasive biomarkers are urgently needed to guide perioperative treatment selection.
年,卷(期): 2026, 23(9)
机标分类号: TP301.6 O213.2 F713.36
在线出版日期: 2026年10月13日